Abstract
Long-Term Follow-up of Idelalisib Monotherapy in Patients with Double-Refractory Marginal Zone Lymphoma or Lymphoplasmacytic Lymphoma/ Waldenstrom's Macroglobulinemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have